drugset / Trial / NCT03353363
Wound Infiltration of Liposomal Bupivacaine v Plain Bupivacaine for Post-Op Pain Control in Elective Cesarean Delivery
RandomizedParallel-groupTriple-blindTreatment
Summary
Randomized double blind placebo controlled trial to compare the post-operative pain control advantages of post-incisional wound infiltration with liposomal bupivacaine to plain bupivacaine in patients presenting for elective caesarean delivery.
Timeline
- Start
- 2017-10-18
- Primary completion
- 2018-10-18
- Completion
- 2019-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 100 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
Indications
No indication recorded.